Dr. Al Zand, Cardioloog & Dr. Al-Haidari, Radioloog
0654.930.043 · rovalta.com · 28/09/2026
Dr. Al Zand, Cardioloog & Dr. Al-Haidari, Radioloog
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBODr. Al Zand, Cardioloog & Dr. Al-Haidari, Radioloog is a Private limited company incorporated in 2016. Its registered office is in Oudenaarde.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0654.930.043
- Incorporation
- 24/05/2016
- Legal form
- Private limited company
- Registered office
- Vaddenhoek 40
9700 Oudenaarde · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/09/2025
Financials
Source · NBB, 9 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 296,6 k € | -17.3% | 358,7 k € | +0.9% | 355,6 k € | +20.3% | 295,5 k € | -12.6% | 338,1 k € |
| EBITDA | 279,4 k € | -21.4% | 355,4 k € | +1.1% | 351,7 k € | +20.7% | 291,3 k € | -12.5% | 333,1 k € |
| Operating result | 260,3 k € | -1.2% | 263,6 k € | +12.3% | 234,6 k € | +17.1% | 200,4 k € | -8.7% | 219,6 k € |
| Net result | 180,2 k € | -2.4% | 184,5 k € | +13.8% | 162,2 k € | +17.2% | 138,4 k € | -8.4% | 151 k € |
| Balance sheet | |||||||||
| Equity | 440,7 k € | +1.2% | 435,6 k € | +8.6% | 401 k € | +18.4% | 338,9 k € | +12.8% | 300,5 k € |
| Total assets | 1,3 M € | +21.0% | 1,1 M € | -4.7% | 1,1 M € | -0.6% | 1,1 M € | -2.8% | 1,2 M € |
| Cash | 198,1 k € | +125% | 87,9 k € | -43.0% | 154,2 k € | -63.7% | 424,7 k € | +6.5% | 398,8 k € |
| Debts | 849,5 k € | +35.3% | 627,8 k € | -12.8% | 720,1 k € | -9.3% | 793,7 k € | -8.5% | 867,7 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/20252 active · 2 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Alia's Al Haidari | Directorsince 19/05/2016 | |
Bakr Al Zand | Directorsince 19/05/2016 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Alia'a AL Haidari | Directorsince 19/05/2016 | |
Alia'a Alhaidari | Directorsince 19/05/2016 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 08/04/2026 | 22/04/2025 | 26/04/2024 | 24/04/2023 | 15/04/2022 | 27/04/2021 |
| General meeting | 27/03/2026 | 28/03/2025 | 29/03/2024 | 31/03/2023 | 25/03/2022 | 26/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2025 | 27/03/2026 | 08/04/2026 | Dutch | |
| Micro model | 30/09/2024 | 28/03/2025 | 22/04/2025 | Dutch | |
| Micro model | 30/09/2023 | 29/03/2024 | 26/04/2024 | Dutch | |
| Micro model | 30/09/2022 | 31/03/2023 | 24/04/2023 | Dutch | |
| Micro model | 30/09/2021 | 25/03/2022 | 15/04/2022 | Dutch | |
| Micro model | 30/09/2020 | 26/03/2021 | 27/04/2021 | Dutch | |
| Micro model | 30/09/2019 | 27/03/2020 | 27/04/2020 | Dutch | |
| Micro model | 30/09/2018 | 29/03/2019 | 29/04/2019 | Dutch | |
| Micro model | 30/09/2017 | 30/03/2018 | 02/05/2018 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20252 active · 2 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Alia's Al Haidari | Directorsince 19/05/2016 | |
Bakr Al Zand | Directorsince 19/05/2016 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Alia'a AL Haidari | Directorsince 19/05/2016 | |
Alia'a Alhaidari | Directorsince 19/05/2016 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Vaddenhoek 40, 9700 OudenaardeCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00074681 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr. Al Zand, Cardioloog & Dr. Al-Haidari, RadioloogCurrent | CBE | |
| DR. AL ZAND & DR. AL HAIDARI | accounts 2021 → 2025 | Accounts 2025 · 2026-00074681 |
Events
- 2025Annual accounts 2025180,2 k €↓
- 2024Annual accounts 2024184,5 k €↑
- 2023Annual accounts 2023162,2 k €↑
- 2022Annual accounts 2022138,4 k €↓
- 2021Annual accounts 2021151 k €↑
- 2020Annual accounts 2020124,7 k €↑
- 2019Annual accounts 201961,8 k €↑
- 2018Annual accounts 201829,6 k €↑
- 2017Annual accounts 20174,7 k €
- 24/05/2016IncorporationPrivate limited company